Publication no. P-312BACKGROUND AND OBJECTIVE: Our previous study showed that acute phase liver graft injury not only promotes tumor recurrence, but also induces chemoresistance in recurrent HCC after liver transplantation [1]. Recently, we found that the oxygen carrier 'YQ23' significantly ameliorates hepatic IR injury and prevents tumor recurrence [2]. Here, we intended to explore the novel therapeutic strategy using oxygen carrier 'YQ23' to sensitize chemotherapy in ...postprin
